AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
AstraZeneca and Amgen have released topline data from a Phase III trial of its inflammatory therapy, Tezspire (tezepelumab) in patients…
All articles by Phalguni Deswal
Phalguni Deswal
@Phalguni_GD
Phalguni Deswal is reporter in the healthcare and pharmaceutical sector. With a background in medicine, Phalguni has experience working in the Indian healthcare sector. Phalguni is interested in metabolic drug therapies, digital health technologies, and drug development.
-
-
Castle boasts melanoma test’s capacity to reduce unnecessary testing
Castle Biosciences has released data from a multi-centre DECIDE study showing the impact of integrating its DecisionDx-Melanoma test results into…
-
Intra-Cellular bolsters Caplyta data with another Phase III win
Having raised the full-year sales guidance for Caplyta (lumateperone) a week ago, Intra-Cellular Therapeutics has reported positive topline data from…
-
Allurion boasts over 17% weight loss with swallowable balloon device
Allurion Technologies has presented data from two studies showing the efficacy of its swallowable gastric balloon in causing significant weight…
-
Biofrontera stock climbs as drug-device succeeds in Phase III skin cancer trial
US-based company Biofrontera has announced topline results from a Phase III trial evaluating its drug-device therapy, Ameluz gel and photodynamic…
-
Roche’s Alzheimer’s test shows high negative predictive value
Roche has presented new late-breaking data from a prospective trial showing that its Elecsys amyloid plasma panel can rule out…
-
Spero’s stock slides after antibiotic flops in Phase II trial
Spero Therapeutics has suspended the development of its antibiotic SPR720, after the therapy failed to meet the primary endpoint in a Phase…
-
Bavarian eyes mpox vaccine label expansion to include toddlers, kickstarts Phase II trial
Bavarian Nordic is looking to expand the approval label of its MVA-BN mpox/smallpox vaccine to include children between two and…
-
Abbott starts new trial to assess early use benefit of HeartMate 3
Abbott has launched a “first-of-its-kind” trial to identify advanced heart failure patients who could potentially benefit from early advanced therapy…
-
Luna Diabetes trials automated wearable insulin pump
US-based device company Luna Diabetes has initiated a pivotal trial evaluating its automated closed-loop insulin technology, the Luna System, in…